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ABSTRACT 
By various chromatographic separations, four phenolic glycosides, methyl salicylate 2-O-
triglycoside (1), icariside E5 (2), quercetin 3-O-rutinoside (3), and isorhamnetin 3-O-rutinoside 
(4) were isolated from the methanol extract of the whole plant of Physalis angulata. Their 
structures were determined by 1D-, 2D-NMR spectroscopic analyses and by comparison with 
reported data. Compounds 3 exhibited significant hepatoprotective activity with an EC50 value of 
17.08 µg/mL. This is the first report of 1-4 from Physalis angulata. 
Keywords: Physalis angulata, phenolic glycoside, hepatoprotective effect. 
1. INTRODUCTION 
Physalis is a genus of herbaceous plants in the Solanaceae family. The genus comprises 
approximately 120 species, mainly distributed worldwide in tropical and temperate regions. As 
reported by Vo Van Chi [1], in Vietnam the genus Physalis includes 4 species: P. angulata, P. 
alkekengi, P. peruviana and P. minima. Most species of the genus Physalis have been used for a 
long time in the ethnomedical folk traditions of Asian and American populations to treat 
different illnesses, such as malarial, asthma, hepatitis, dermatitis, liver disorders, and as an 
antimycobacterial, anticancer, antileukemic, antipyretic, and immune-modulatory agent [2].  
In term of liver disorder, 20 methanol extracts of Thai Binh’s medicinal plants (Annona 
glabra (leave and fruit), Annona squamosa, Michelia alba, Glinus oppositifolius, Hibiscus 
tiliaceus, Hibiscus rosa-sinensis, Euphorbia pulcherrima, Euphorbia hirta, Chenopodium 
ficifolium, Chenopodium ambrosioides, Suaeda maritima, Ricinus communis, Physalis angulata, 
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Cudrania tricuspidata, Solanum nigrum, Datura metel, Solanum procumbens, Heliotropium 
indicum, Lactuca indica) were screened on the protective effects against hydrogen peroxide 
induced Balb/c mice hepatocytes damage. The results indicated that the methanol extract of P. 
angulata exhibited great protective activity, with an EC50 value of 56.0 ± 14.0 µg/mL. Thus, it 
was subjected to chemical study to clarify active constituents. Our results report four phenolic 
glycosides, methyl salicylate 2-O-triglycoside (1), icariside E5 (2), quercetin 3-O-rutinoside (3) 
and isorhamnetin 3-O-rutinoside (4) from the water-soluble fraction of the methanol extract of    
P. angulata. This is the first report of 1, 2 and 4 from this genus [2]. 
2. MATERIALS AND METHODS 
2.1. Plant Material  
Whole plant of Physalis angulata were collected at Thai Binh province, Vietnam, in 
August, 2015. Its scientific name was identified by Dr. Tran Thi Phuong Anh, Vietnam National 
Museum of Nature. A voucher specimen (TB14.2015) is deposited at the Herbarium of Institute 
of Marine Biochemistry, VAST. 
2.2. General experimental procedures  
The 1H-NMR (500 MHz) and 13C-NMR (125 MHz) spectra were recorded on a Bruker 
AM500 FT-NMR spectrometer and TMS was used as an internal standard. Column 
chromatography was performed using a silica gel (Kieselgel 60, 70 - 230 mesh and 230 - 400 
mesh, Merck, Whitehouse Station, NJ) or RP-18 resins (30 - 50 µm, Fuji silysia Chemical Ltd.), 
and thin layer chromatography (TLC) was performed using pre-coated silica-gel 60 F254 (0.25 
mm, Merck) and RP-18 F254S plates (0.25 mm, Merck). 
2.3. Extraction and isolation 
The dried and powdered whole plants of Physalis angulata (3.0 kg) were sonically extracted 
with methanol at 50 °C for three times (4.0 L each). After removal of the solvent, the methanol 
extract (110 g) was suspended in distilled water (1.5 L) and successively partitioned with 
dichloromethane and ethyl acetate (three time, 1.5 L each) to give corresponding soluble 
extracts, dichloromethane (PAD, 34.5 g), ethyl acetate (PAE, 3.6 g), and water soluble layers 
(PAW, 71.9 g). The water layer was then passed through Diaion HP-20 column chromatography, 
washed with distilled water and desorbed with methanol/water (25 %, 50 %, 75 % and 100 % 
volume of methanol, each 1.0 L, stepwise) to give four fractions PAW1−PAW4. Fraction PAW2 
was chromatographed on a silica gel column, eluting with dichloromethane/methanol/water 
(3/1/0.1, v/v/v) to give two sub-fractions PAW2A-PAW2B. Sub-fraction PAW2A was firstly 
chromatographed on a reverse phase C18 column, eluting with methanol/water (2/1, v/v), and 
then further purified on a Sephadex LH-20 column, eluting with methanol/water (3/1, v/v) to 
obtain compound 2 (12.0 mg). Fractions PAW3A and PAW3B were obtained after CC of the 
sub-fraction PAW2A on a reverse phase C18 column, eluted with acetone/water (1/1, v/v). 
Fraction PAW3B was purified by a silica gel CC, eluting with ethyl acetate/methanol/water 
(15/1/0.05, v/v/v) to obtain compound 1 (9.0 mg). Fraction PAW4 (3.1 g) was separated by a 
silica gel CC, eluting with dichloromethane/ methanol/ water (2/1/0.1, v/v/v) to give two 
fractions PAW4A and PAW4B. Fraction PAW4A was chromatographed on a reverse phase C18 
column, eluting with methanol/ water (1/2, v/v) and further purified by a silica gel CC, eluted 
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with dichloromethane/ methanol/ water (2/1/0.05, v/v/v) to obtain compounds 3 (19.0 mg) and 4 
(12.0 mg).  
 
Figure 1. Chemical structures of compounds 1-4. 
Methyl salicylate 2-O-triglycoside (1): White, amorphous powder; MF: C27H28N2O4, MW: 
444, 1H (CD3OD, 500 MHz)- and 13C-NMR (CD3OD, 125 MHz), see Table 1. 
Icariside E5 (2): Amorphous powder; MF: C25H26N2O3, MW: 402, 1H (CD3OD, 500 MHz)- 
and 13C-NMR (CD3OD, 125 MHz), see Table 1. 
Quercetin 3-O-rutinoside (3): Pale yellow powder; MF: C27H30O16, MW: 610. 1H-NMR 
(CD3OD, 500 MHz) δH (ppm): 6.18 (1H, s, H-6), 6.37 (1H, s, H-8), 7.66 (1H, s, H-2′), 6.86 (1H, d, 
J = 8.0 Hz, H-5′), 7.61 (1H, d, J = 8.0 Hz, H-6′), 5.05 (1H, d, J = 7.6 Hz, H-1′′), 3.46 (1H, 
overlapped, H-2′′), 3.41 (1H, overlapped, H-3′′), 3.28 (1H, overlapped, H-4′′), 3.34 (2H, m, H-5′′, 
Hb -6′′), 3.78 (1H, d, J = 10.0 Hz, Ha -6′′), 4.49 (1H, s, H-1′′′), 3.27 (1H, overlapped, H-2′′′), 3. 53 
(1H, overlapped, H-3′′′), 3.62 (1H, overlapped, H-4′′′), 3.43 (1H, overlapped, H-5′′′), and 1.10 (3H, 
d, J = 6.0 Hz, H-6′′′). 13C-NMR (CD3OD, 125 MHz) δC (ppm): 159.4 (C-2), 135.6 (C-3), 179.3 (C-
4), 162.8 (C-5), 100.0 (C-6), 166.0 (C-7), 94.9 (C-8), 158.4 (C-9), 105.5 (C-10), 123.0 (C-1′), 
116.0 (C-2′), 145.8 (C-3′), 149.8 (C-4′), 117.7 (C-5′), 123.5 (C-6′), 104.7 (C-1′′), 75.6 (C-2′′), 78.1 
(C-3′′), 71.3 (C-4′′), 77.1 (C-5′′), 68.6 (C-6′′), 102.4 (C-1′′′), 72.0 (C-2′′′), 72.1 (C-3′′′), 73.9 (C-
4′′′), 69.7 (C-5′′′), and 17.9 (C-6′′′). 
Isorhamnetin 3-O-rutinoside (4): Pale yellow powder; MF: C28H32O16, MW: 624. 1H-
NMR (CD3OD, 500 MHz) δH  (ppm): 6.16 (1H, s, H-6), 6.33 (1H, s, H-8), 7.96 (1H, s, H-2′), 
6.91 (1H, d, J = 8.5 Hz, H-5′), 7.63 (1H, d, J = 8.5 Hz, H-6′), 3.96 (3H, s, OCH3), 5.17 (1H, d, J 
= 7.5 Hz, H-1″), 3.42 (1H, overlapped, H-2″), 3.38 (1H, overlapped, H-3″), 3.27 (1H, 
overlapped, H-4″), 3.48 (1H, m, H-5″), 3.40 (1H, d, J = 11.0 Hz, Ha -6′′, 3.83 (1H, d, J = 11.0 
Hz, Hb -6′′), 4.54 (1H, br s, H-1″′), 3.51 (1H dd, J = 3.5, 9.5 Hz, H-2″′), 3.64 (1H, overlapped, 
H-3″′), 3.29 (1H, overlapped, H-4″′), 3.46 (1H, m, H-5″′), and 1.13 (d, J = 6.5 Hz, H-6″′). 13C-
NMR (CD3OD, 500 MHz) δC (ppm):158.4 (C-2), 135.3 (C-3), 178.8 (C-4), 162.7 (C-5), 101.2 
(C-6), 169.9 (C-7), 95.8 (C-8), 158.8 (C-9), 104.6 (C-10), 122.9 (C-1′), 114.5 (C-2′), 148.4 (C-
3′), 151.1 (C-4′), 116.2 (C-5′), 124.0 (C-6′), 56.7 (3′-OCH3), 104.8 (C-1″), 75.9 (C-2″), 77.3 (C-
3″), 71.6 (C-4″), 78.2 (C-5″), 68.6 (C-6″), 102.5 (C-1″′), 72.3 (C-2″′), 72.1 (C-3″′), 73.9 (C-4″′), 
69.8 (C-5″′), and 17.9 (C-6″′). 
2.4. Hepatocyte protection assay 
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The primary hepatocytes freshly isolated from BALB/c mice was seeded in to 96 well plate at 
the concentration of 1 × 104 cells per well. After 24 hours of growing in the incubator (5 % CO2, 
37 oC, 100 % humidity), cells were treated with different concentrations of testing compounds 
for following 2 hours. 100 µM H2O2 was then added per well and testing plate stayed for another 
2 h. In order to determine the number of living hepatocytes after H2O2 exposure as well as the 
tested samples’ protective activities, 50 µl of MTT (1mg/ml) was added into each well and 
incubated for 4 hours at the 37oC. The supernatant was discarded and then 100 µl/well of DMSO 
100% was added. The optical density (OD) values of formazan solution were determined by 
Microplate Reader at 492 nm. The survival percentage of hepatocytes was calculated as the 
following: 
                                               [OD(sample) - OD(H2O2)] x 100 
                % survival =  
                                                 OD(cell) - OD(H2O2) 
4. RESULTS AND DISCUSSION 
Compound 1 was obtained as a white amorphous powder. The 1H-NMR of 1 showed the 
presence of four protons of a 1,2-disubstituted benzene ring at δH 7.79 (1H, d, J = 7.5 Hz), 7.46 
(1H, t, J = 7.5 Hz), 7.33 (1H, d, J = 8.5 Hz), and 7.09 (1H, t, J = 7.5 Hz); and a methoxy signal 
at δH 3.89 (3H, s). Besides, three anomeric protons were observed at δH 5.34 (1H, d, J = 7.0 Hz), 
4.86 (1H, overlapped), and 4.31 (1H, d, J = 7.0 Hz) suggesting the presence of a trisaccharide 
moiety. The 13C-NMR and HSQC spectrum of 1 gave 25 carbon signals, including a carbonyl 
carbon at δC 167.9, six aromatic carbons at δC at 157.6 (C), 135.2 (CH), 132.4 (CH), 122.6 (CH), 
121.2 (C), and 116.5 (CH); a methoxy at δC 52.6. The anomeric carbon signal at δC 105.3 and 
oxymethylene carbon at δC 66.8 suggested the presence of a xylopyranose. Besides, two 
anomeric carbon signals were observed at δC 99.6 and 104.3 together with an oximethine carbon 
at δC 82.9; and two oxymethylene carbons at δC 69.6 and 61.4 were indicative for the presence of 
the 2-O-β-D-glucopyranosyl-(1→2)-[O-β-D-xylopyranosyl-(1→6)]-O-β-D-glucopyranoside 
fragment. The NMR data of 1 were similar to methyl salicylate 2-O-triglycoside [3]. 
The structure of 1 was identified with the aid of HSQC and HMBC spectra (Fig. 2). HMBC 
correlations between anomeric protons H-1′ (δH 5.34, Glc1) and C-1 (δC 157.5); H-1″ (δH 4.86, 
Glc2) and C-2′ (δC 82.9); H-1ʹ″ (δH 4.31, Xyl) and C-6′ (δC 69.6) were indicative for the 2-O-β-
D-glucopyranosyl-(1→2)- [O-β-D-xylopyranosyl-(1→6)]-O-β-D-glucopyranoside structure; and 
the position of methoxy at C-7 was confirmed by HMBC correlation between methoxy proton 
(δH 3.89) and C-7 (δC 167.9). Based on above evidence, the structure of 1 was established as 
methyl salicylate 2-O-triglycoside [3]. 
Compound 2 was obtained as amorphous powder. The 1H-NMR of 2 showed two protons 
of a double bond (trans configuration) at δH 6.58 (1H, d, J = 16.0 Hz) and 6.33 (1H, dt, J = 5.5, 
16.0 Hz); three protons of a 1,3,4-trisubstituted aromatic ring at δH 6.60 (1H, d, J = 1.5 Hz), 6.57 
(1H, br s), and 6.50 (1H, dd, J = 1.5, 8.0 Hz); two other singlet aromatic protons at δH 6.95 (1H, 
br s), and 6.94 (1H, brs); two methoxy protons at δH 3.85 (3H, s) and 3.71 (3H, s). The signal of 
an anomeric proton at δH 4.70 (1H, d, J = 7.0 Hz) suggested the presence of one sugar moiety. 
The 13C-NMR and HSQC spectrum of 2 revealed 26 carbons, including two olefin carbons 
at δC 131.5 and 129.7; six carbons of a β-D-glucose moiety at δC 105.4, 76.0, 77.9, 71.3, 78.1, 
and 62.5; a methine carbon at δC 42.8; two oxymethylenes and a methylene at δC 66.8, 63.7 and 
39.2; two methoxy carbons at δC 56.4 and 56.3; and 12 carbons of two aromatic rings including 7 
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quaternary carbons and 5 methine carbons. The NMR data of 2 were very similar to those of 
ircariside E5 [4]. The HMBC correlations (Fig. 2) from H-2 (δH 6.57) and H-5 (δH 6.60) to C-1 
(δC 133.2), C-3 (δC 148.4), and C-4 (δC 145.4); from H-6 (δH 5.50) to C-4 (δC 145.4) and C-7 (δC 
39.2); and from methoxy proton (δH 3.71) and C-3 (δC 148.4) confirmed the position of methoxy 
group at C-3. The HMBC correlations between H-9′ (δH 4.25) and C-7′ (δC 131.5)/ C-8′ (δC 
129.7); H-7′ (δH 6.58) and C-2′ (δC 109.1)/ C-6′ (δC 119.2); H-2′ (δH 6.95)/H-6′ (δH 6.94)/H-1″ 
(δH 4.70, Glc) and C-4′ (δC 145.0); and between methoxy proton (δH 3.85) and C-3′ (δC 153.5) 
confirmed the position of the double bond at C-7′, glucose moiety at C-4′, and methoxy group at 
C-3′, respectively. Base on above evidence and comparison with the reported data, the chemical 
structure of 2 was identified as icariside E5 (Fig. 1). 
Compounds 3 and 4 were identified as quercetin 3-O-rutinoside [5] and isorhamnetin 3-O-
rutinoside [6], respectively, based on spectral evidences, which were in agreement with those of 
the reported data in literature. 
 
Figure 2. Key HMBC correlations of 1 and 2. 
Table 1. 1H- and 13C-NMR data for 1-2 and reference compounds. 
No. 
 1  
No. 
 2 
#
δC
d
 δC
a,b
 δH
a,c
 (mult., J in Hz)  $δCa δCa,b δH
a,c
 (mult., J in 
Hz) 
1 121.0 121.2 -  1 133.2 133.2 - 
2 157.4 157.5 -  2 116.0 115.7 6.57 (br s) 
3 116.4 116.5 7.33 (d, 8.5)  3 148.3 148.4 - 
4 134.1 135.2 7.46 (t, 7.5)  4 145.3 145.4 - 
5 121.5 122.6 7.09 (t, 7.5)  5 114.1 113.8 6.60 (d, 1.5) 
6 131.6 132.4 7.79 (d, 7.5)  6 122.8 122.6 6.50 (dd, 1.5, 8.0) 
7 166.3 167.9 -  7 39.1 39.2 2.74 (dd, 9.5, 14.0) 2.99 (dd, 6.0, 14.0) 
7-
OMe 52.0 52.6 3.89 (s) 
 8 43.0 42.8 3.98 (m) 
3-O-Glucosyl  9 66.5 66.8 3.70 (m) 3.80 (d, 11.0) 
1' 100.0 99.6 5.34 (d, 7.0)  1' 135.4 135.4 - 
2' 82.7 82.9 3.85*  2' 108.7 109.1 6.95 (br s) 
3' 77.8 77.4 3.72 (t, 8.5)  3' 153.4 153.5 - 
4' 71.1 70.86 3.48*  4' 145.0 145.0 - 
5' 77.5 77.6 3.99*  5' 139.0 139.0 - 
6' 69.5 69.6 
3.78 (dd, 1.5, 11.5) 
4.11 (d, 11.5) 
 
6' 118.7 119.2 6.94 (br s) 
  
Hoang Le Tuan Anh, Duong Thi Dung, et al 
 
 
166 
2′′-O-Glucosyl  7' 131.5 131.5 6.58 (d, 16.0) 
1'' 105.7 104.3 4.86*  8' 129.6 129.7 6.33 (dt, 5.5, 16.0) 
2'' 76.8 76.0 3.23 (m)  9' 63.5 63.7 4.25 (dd, 1.0, 6.0) 
3'' 78.1 77.1 3.16*  3-OMe 56.0 56.3 3.71 (s) 
4'' 71.2 70.6 3.40*  3'-OMe 55.9 56.4 3.85 (s) 
5'' 78.3 77.3 3.14 (m)  4′-O-Glucosyl 
6'' 62.3 61.4 
3.17 (d, 11.5) 
3.50* 
 
1'' 106.0 105.4 4.70 (d, 7.0) 
6′′-O-Xylosyl  2'' 75.7 76.0 3.48 (dd, 7.0, 8.5) 
1''' 105.9 105.3 4.31 (d, 7.0)  3'' 77.5 77.9 3.43 (t, 8.5) 
2''' 75.0 75.0 3.19 (d, 2.5)  4'' 71.0 71.3 3.39 (t, 8.5) 
3''' 78.1 77.4 3.39*  5'' 77.8 78.1 3.13 (m) 
4''' 70.8 71.1 3.51* 
 
6'' 62.3 62.5 
3.68* 
3.79 (d, 12.0) 
5''' 67.1 66.8 
3.10 (t, 11.5) 
3.83 (dd, 5.0, 11.5) 
 
    
Measured in a) CD3OD, b)125 MHz, c)500 MHz, d) pyridine. #δC of methyl salicylate 2-O-triglycosides [3], $δC of 
icariside E5 [4], *overlapped signal. 
All compounds were evaluated for their protective effects on H2O2 induced Balb/c mice 
hepatocytes injury. Briefly, hepatocytes were isolated from the livers of healthy Balb/c mice. 
The cells were cultured, treated with the compounds and H2O2. The damaged cells were 
measured via MTT assay and the protective effects of the samples were calculated by comparing 
cell viability with the vehicles (Table 2).  
Table 2. Hepatoprotecive effects of compounds 1-4. 
Concentration 
(µg/ml) 1 2 3 4 Curcumin 
100 5.19 8.65 42.12 4.22 62.14 
20 13.57 13.73 52.14 0.71 39.29 
4 11.03 10.08 28.33 - 18.33 
0.8 - - 7.86 - 4.52 
EC50 >100 >100 17.08 >100 4.56 
(-) Hepatoprotective effects were not observed. 
In comparison with positive control, curcumin (EC50 4.6 ± 0.3 µg/mL), compound 3 
exhibited significant protective activity (EC50 17.08 µg/mL), while others were inactive (EC50 > 
100 µg/mL). The results suggest that the free hydroxyl group in position C-3′ of compound 3 
may play an important role in its hepatoprotective activity. 
4. CONCLUSIONS 
By various chromatographic separations, four phenolic glycosides, methyl salicylate 2-O-
triglycoside (1), icariside E5 (2), quercetin 3-O-rutinoside (3), and isorhamnetin 3-O-rutinoside 
(4) were isolated from the methanol extract of the whole medicinal plant Physalis angulata 
collected in Thai Binh province, Vietnam. Their structures were determined by 1D-, 2D-NMR 
spectroscopic analyses and by comparison with reported data. Compounds 3 exhibited 
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significant hepatoprotective activity with an EC50 value of 17.08 µg/mL. This is the first report 
of 1-4 from Physalis angulata. 
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